Tilray Inc (NASDAQ:TLRY – Get Free Report) dropped 4.1% on Thursday . The company traded as low as $1.75 and last traded at $1.77. Approximately 6,649,915 shares traded hands during trading, a decline of 77% from the average daily volume of 28,947,635 shares. The stock had previously closed at $1.84.
Analyst Ratings Changes
TLRY has been the topic of a number of recent research reports. CIBC lowered their target price on Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 10th. Alliance Global Partners increased their target price on Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a research note on Friday, April 5th. Finally, Canaccord Genuity Group lowered their target price on Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th.
View Our Latest Analysis on TLRY
Tilray Stock Performance
Institutional Investors Weigh In On Tilray
A number of large investors have recently modified their holdings of TLRY. Clear Street Markets LLC acquired a new stake in shares of Tilray in the 3rd quarter valued at $25,000. Lake Street Financial LLC acquired a new stake in shares of Tilray in the 3rd quarter valued at $28,000. Gainplan LLC acquired a new stake in shares of Tilray during the 4th quarter valued at $28,000. Simplicity Wealth LLC acquired a new stake in shares of Tilray during the 1st quarter valued at $28,000. Finally, RPO LLC acquired a new stake in shares of Tilray during the 4th quarter valued at $28,000. Institutional investors and hedge funds own 9.35% of the company’s stock.
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Further Reading
- Five stocks we like better than Tilray
- What Is WallStreetBets and What Stocks Are They Targeting?
- MarketBeat Week in Review – 4/22 – 4/26
- How to Invest in Blue Chip Stocks
- 3 Stocks Leading the U.S. Agriculture Comeback
- Profitably Trade Stocks at 52-Week Highs
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.